Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis. (Q40220053)
Jump to navigation
Jump to search
scientific article published on 9 May 2017
- Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis. |
scientific article published on 9 May 2017 |
|
Statements
Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis (English)
Adriana Aguado-Martínez
Javier Moreno-Gonzalo
Matthew A Hulverson
Ryan Choi
Molly C McCloskey
Lynn K Barrett
Kayode K Ojo
Wes Van Voorhis
Andrew Hemphill
1 reference
1 reference
1 reference
1 reference